OR WAIT 15 SECS
© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
November 27, 2020
A recent study showed “alarming” rates of reported loneliness, anxiety, depression, and substance use in young adults during COVID-19.
Here’s a roundup of this week’s coronavirus-related news.
November 25, 2020
Technology will help you identify potential reimbursement problems before they trigger reduced payments or claims audits.
Tim Suther, senior vice president of data solutions at Change Healthcare, discusses a new Social Determinants of Health Analytics resource.
As coronavirus disease 2019 (COVID-19) cases rise across the country, members of the MJH Life Sciences COVID-19 Coalition shared their perspectives on pandemic containment efforts.
Lumasiran (Oxlumo; Alnylam Pharmaceuticals) is the first drug approved for the treatment of primary hyperoxaluria type 1, a rare genetic disorder.
November 23, 2020
The new model will test a new way to lower increasing drug prices for patients paying for drugs under Medicare Part B.
One vaccine dosing regimen for AZD1222 showed 90% efficacy, according to investigators at the University of Oxford.
Here’s a preview of the featured content to watch for this week on Drug Topics®.
November 20, 2020
Here's the roundup of this week's coronavirus-related news.